CompletedEarly Phase 1

Non Invasive Oral Cancer Screening Among HIV Infected Individuals

United States44 participantsStarted 2016-06-30

Plain-language summary

The goal of this clinical research study is to learn how a new method for performing oral (mouth) exams can help doctors check for suspicious lesions (called premalignant and malignant oral lesions \[PMOL\]) in the mouth of HIV-infected smokers.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. HIV positive individuals seeking dental care at Bering Omega/Houston Area Community Services
✓. Being able to speak English and/or Spanish

Exclusion criteria

✕. patients under 18 years of age
✕. patients current participation in a tobacco cessation program
✕. Patients unwilling or unable to provide consent
✕. Patients declining oral biopsies

What they're measuring

Positive Predictive Value for Premalignant and Malignant oral lesions (PMOL)

Timeframe: 2 weeks

Trial details

NCT IDNCT02823847

SponsorM.D. Anderson Cancer Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-07-26

View on ClinicalTrials.gov More Malignant Neoplasms of Mesothelial and Soft Tissue trials